Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

GlaxoSmithKline

Intuitive Surgical

Johnson & Johnson

Medtronic

Pfizer

Vertex Pharmaceuticals

Healthcare stocks in 2024 are charting an impressive course, emerging as formidable contenders in the investment sphere. After weathering a challenging 2023, these stocks are on the rise, with the S&P 500 Health Care index showcasing an almost 11% rise in the last three months alone.

The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024

CRISPR Therapeutics

CRISPR Therapeutics recently reached a major milestone: the approval of its first product. Teladoc Health is taking steps to optimize efficiency and travel the path to profitability.

Got $100? 2 Top Cathie Wood Stocks to Buy and Hold.

Novavax

Novavax missed out on the biggest opportunity for COVID-19 vaccine revenue, but its investigational covid/flu vaccine may offer it future growth potential. Teladoc Health has put the focus on balancing revenue growth with its quest for profitability, and its efforts are bearing fruit.

Better Recovery Story Buy: Novavax vs. Teladoc

ChargePoint Holdings

Palantir Technologies

Spirit Airlines

SoFi Technologies

Tilray Brands

Twilio

Many of yesterday's meme stocks are today's forgotten remnants collecting dust at the bottom of your portfolio, hopes of a multi-bagger long past abandoned. It's only a loss if you sell, right?

7 Meme Stocks Set to Rebound Before Summer Hits

PURCHASE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release fourth quarter 2023 results on Tuesday, February 20, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Teladoc Health to Announce Fourth Quarter 2023 Financial Results

Amazon

Veeva Systems

Digital health and healthcare technology companies operate in novel, booming sectors and offer unprecedented surge potential to equities investors looking to capitalize on the growing demand for technological solutions in the healthcare industry. The Covid-19 pandemic accelerated the adoption of digital health solutions such as online consultations, remote monitoring and digital prescriptions – on the one hand.

3 Once-in-a-Lifetime Healthcare Technology Stocks With Unprecedented Surge Potential

McKesson

One of the most important sectors not only in the financial markets but also in everyone's life, is the healthcare sector. It can provide investors with good returns due to its constant growth and continuous development, and the more it grows, the more companies grow along with it.

3 Hidden Healthcare Stocks Poised for a Breakout This Year

Teladoc Health's strong position in an industry growing in prominence bodes well for its future. Pfizer is replacing its coronavirus products with a portfolio of newly approved medicines.

A Bull Market Is Here: 2 Cheap Stocks to Buy Right Now

Apple

Abbott Labs

Best Buy

Cigna

Microsoft

ReWalk Robotics

While it doesn't seem like it when you're young, aging happens to everyone and therefore, so-called AgeTech stocks should benefit from inevitability. A buzzword for age-related technology, this concept refers to a rapidly growing field focused on developing and applying innovative solutions to improve the lives of senior citizens.

7 ‘AgeTech' Stocks to Profit From the Booming Longevity Market

Teladoc Health struggled in recent years as it failed to turn rising revenue into profit. But Teladoc's new plan to focus on profitability is bearing fruit, with recent results meeting or beating expectations.

3 Reasons to Buy Teladoc Stock Like There's No Tomorrow

Consumers spend trillions of dollars on healthcare a year, and there are many ways to invest in this industry. Teladoc has reduced its losses and boosted revenue, but investors need to watch the business closely.

2 of the Best Stocks to Buy on a Dip in 2024

Teladoc's latest earnings call shows evidence of renewed focus on improving profitability, with adjusted EBITDA growing 73% YoY. The company's Integrated Care segment is driving superior operational outcomes, with revenue growth and increased EBITDA margins. While competitive threats remain, Teladoc's management is committed to improving profitability and has shown success in replacing competitors & driving product adoption, leaving upside for the stock.

Teladoc: Stock Has Likely Found A Floor With Upside Ahead

Teladoc Health is a leading provider of long-distance health services. Shares of Teladoc Health have been beaten down to an attractive valuation.

2 Reasons to Buy Teladoc Health Stock, and 1 Reason to Avoid It Like the Plague

Teladoc Health should benefit from the weight loss management opportunity in the telehealth sector. Employers are becoming more willing to cover the high costs of GLP-1s with the right management programs in place. The stock is cheap trading below 10x forward EBITDA estimates.

Teladoc Health: Weight Management Rescue

Industry leader releases fourth annual Corporate Social Responsibly (CSR) report Industry leader releases fourth annual Corporate Social Responsibly (CSR) report

Teladoc Health highlights progress in advancing care access, sustainability in new report

Chewy

Etsy

Etsy and Chewy are e-commerce businesses that have shown their ability to keep customers coming back -- even during tough times. Teladoc Health has put a new focus on the path to profitability, and its efforts are bearing fruit.

These 2023 Stock Market Losers Could Take Off in 2024

UiPath

Upstart Holdings

In the fast-paced world of tech investments, the quest for the next tech gem is akin to navigating a complex maze. As the tech landscape evolves, three standout stocks are positioned as potential game-changers with the capacity to double in value.

The Millionaire's Roadmap: 3 Tech Stocks With the Potential to Double

Amylyx Pharmaceuticals

Boston Scientific

Globus Medical

iRhythm Technologies

Moderna

While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio. If I had to boil it down to one phrase, it would be permanent relevance.

7 Healthcare Stocks Taking Medicine to the Next Level

Bear markets always have led to bull markets, so there's reason to be optimistic about the future. To prepare for better market times, buy quality growth stocks -- they generally thrive in strong market environments.

My 5 Top Growth Stocks to Buy Hand Over Fist for 2024

Intellia Therapeutics

From “undiscovered” biotech stocks to bigger companies that have fallen off investors' radar screens, you can uncover top buys for $100 or less. These players could help you score a long-term win.

The Top Healthcare Stocks to Buy With $100

Teladoc Health has been steadily expanding its business over the past year. Its losses have become more modest, and it's no longer incurring billions in impairment charges.

Is Teladoc Health Stock a Buy Now?

Datadog

GitLab

In the fast-paced world of tech, the quest for the next big breakthrough stocks often resembles a high-stakes gamble. Yet, amidst the volatility, a tantalizing promise echoes the opportunity to ride the wave of a 6X surge in the tech stocks by 2027.

Future Fortune: 3 Groundbreaking Tech Stocks Poised for a 600% Surge by 2027

Teladoc has made significant progress along the road to recovery. Pfizer has a better story than many investors realize.

A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now

Ginkgo Bioworks Holdings

Cathie Wood has loaded up her portfolio with tomorrow's potential healthcare game changers. The superstar investor's commitment to innovation helped her flagship fund jump more than 60% last year.

3 Cathie Wood Stocks to Start Off Your New Year Right

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic Presents at 42nd Annual JPMorgan Healthcare Conference Transcript

News for Teladoc Stock (TDOC)